- Preview Available
- Scholarly Journal
MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial
Nature Communications; London Vol. 16, Iss. 1, (2025): 423.
DOI:10.1038/s41467-024-55316-5
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.